Opus Genetics, Inc. Shareholders' Equity
Opus Genetics, Inc. (IRD) had Shareholders' Equity of -$12.99 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent -$12.99M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$45.84M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $15.35M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $5.97M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$12.99M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$45.84M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $15.35M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $5.97M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $17.47M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $5.07M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $6.72M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $34.30M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $40.64M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $46.06M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $49.91M 10-K · filed 2026-03-12 | |
| 2023-09-30 | $50.28M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $37.70M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $41.25M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $46.24M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $11.88M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $14.60M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $17.27M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $22.22M 10-K · filed 2024-03-08 | |
| 2021-09-30 | $20.57M 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $22.55M 10-Q · filed 2022-11-04 | |
| 2021-03-31 | $9.82M 10-Q · filed 2022-11-04 | |
| 2020-12-31 | -$13.47M 10-K · filed 2023-03-30 | |
| 2020-09-30 | -$9.41M 10-Q · filed 2021-11-12 | $5.71M 10-Q · filed 2020-10-29 |
| 2020-06-30 | -$8.78M 10-Q · filed 2021-11-12 | $7.00M 10-Q · filed 2020-08-14 |
| 2020-03-31 | -$8.46M 10-Q · filed 2021-11-12 | $9.45M 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$7.56M 10-K · filed 2022-03-24 | $9.96M 10-K · filed 2020-02-21 |
| 2019-09-30 | $11.76M 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $13.62M 10-Q · filed 2020-10-29 | |
| 2019-03-31 | $15.94M 10-Q · filed 2020-08-14 | |
| 2018-12-31 | -$1.70M 10-K · filed 2021-03-11 | $10.56M 10-K · filed 2019-03-07 |
| 2018-09-30 | $6.41M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $11.42M 10-Q · filed 2019-11-06 | |
| 2018-03-31 | $14.97M 10-Q · filed 2019-08-07 | |
| 2017-12-31 | $16.77M 10-K · filed 2020-02-21 | |
| 2017-09-30 | $15.12M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $15.90M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $1.13M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $17.06M 10-K · filed 2019-03-07 | |
| 2016-09-30 | $17.24M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $15.81M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $17.21M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $18.78M 10-K · filed 2018-03-09 | |
| 2015-09-30 | $17.71M 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $21.43M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $23.38M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $26.58M 10-K · filed 2018-03-09 | |
| 2014-09-30 | $28.60M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $30.31M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $28.03M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $12.63M 10-K · filed 2017-02-24 | |
| 2013-09-30 | $9.85M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $5.50M 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $8.38M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $9.53M 10-K · filed 2016-03-14 | |
| 2012-09-30 | $4.74M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $7.67M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $8.66M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $10.71M 10-K · filed 2014-03-21 | |
| 2011-09-30 | $10.17M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $11.48M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $10.40M 10-K · filed 2014-03-21 | |
| 2009-12-31 | $4.90M 10-K · filed 2014-03-21 | |
| 2008-12-31 | -$2.60M 10-K · filed 2014-03-21 | |
| 2007-12-31 | $958.19K 10-K · filed 2014-03-21 | |
| 2006-12-31 | $3.21M 10-K · filed 2014-03-21 | |
| 2005-12-31 | $4.83M 10-K · filed 2014-03-21 | |
| 2004-12-31 | -$564.17K 10-K · filed 2014-03-21 | |
| 2003-12-31 | $2.48M 10-K · filed 2014-03-21 | |
| 2002-12-31 | $2.71M 10-K · filed 2014-03-21 | |
| 2001-12-31 | $3.89M 10-K · filed 2014-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |